Cefuroxime

Cefuroxime

SCHEMBL123194

CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1.[NaH]

nearest known ligand 0.98

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Cefuroxime. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 8/20 0.98
▸ HSD17B10 Q99714 4/20 0.98
▸ NR1I2 O75469 4/20 0.98
▸ ALDH1A1 P00352 2/20 0.98
▸ PGR P06401 1/20 0.98
▸ TSHR P16473 1/20 0.98
▸ MAPT P10636 7/20 0.84
▸ POLB P06746 2/20 0.84
▸ PKM P14618 2/20 0.84
▸ CTDSP1 Q9GZU7 2/20 0.84
▸ MAPK1 P28482 1/20 0.84
▸ ABCC4 O15439 2/20 0.77
▸ PDE4A P27815 1/20 0.77
▸ KMT2A Q03164 1/20 0.62
▸ SLC22A6 Q4U2R8 2/20 0.58
▸ SLC22A8 Q8TCC7 2/20 0.58
▸ SLC22A11 Q9NSA0 2/20 0.58
▸ ALB P02768 1/20 0.58
▸ PPARG P37231 1/20 0.58
▸ HTR2C P28335 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cefuroxime SCHEMBL41261 1.00 TDP1 (0.98) TDP1HSD17B10NR1I2ALDH1A1PGR
Cefuroxime SCHEMBL4137312 1.00 TDP1 (0.98) TDP1HSD17B10NR1I2ALDH1A1PGR
Cefuroxime SCHEMBL10907122 0.99 TDP1 (1.00) TDP1HSD17B10NR1I2ALDH1A1PGR
Cefuroxime SCHEMBL20535121 0.99 TDP1 (1.00) TDP1HSD17B10NR1I2ALDH1A1PGR
Cefuroxime SCHEMBL40415 0.99 TDP1 (1.00) TDP1HSD17B10NR1I2ALDH1A1PGR
Cefuroxime SCHEMBL1821942 0.99 TDP1 (1.00) TDP1HSD17B10NR1I2ALDH1A1PGR
Cefuroxime SCHEMBL11243712 0.99 TDP1 (1.00) TDP1HSD17B10NR1I2ALDH1A1PGR
Cefuroxime SCHEMBL3861498 0.99 TDP1 (1.00) TDP1HSD17B10NR1I2ALDH1A1PGR
Cefuroxime SCHEMBL2221559 0.99 TDP1 (1.00) TDP1HSD17B10NR1I2ALDH1A1PGR
Cefuroxime SCHEMBL11549178 0.99 TDP1 (1.00) TDP1HSD17B10NR1I2ALDH1A1PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120037191-A Freeze-drying process preparation method of sodium cefuroxime axetil powder injection for injection 浙江惠迪森药业有限公司 2025-05-27 — — CN claimed
CN-119139246-A Cephalosporium oxydanum freeze-dried powder for injection and preparation method thereof 成都倍特药业股份有限公司 2024-12-17 — — CN claimed
CN-117069739-A Preparation method of high-purity sodium cefuroxime axetil 山西千岫制药有限公司 2023-11-17 — — CN claimed
CN-116296745-A Method for detecting impurities in sodium cefuroxime axetil freeze-dried powder for injection 杭州沐源生物医药科技有限公司 2023-06-23 — — CN claimed
CN-109456339-A A kind of synthetic method of Cefuroxime Sodium 湖北凌晟药业有限公司 2019-03-12 — — CN claimed
CN-108926570-A Cephalosporin analog antibiotic is preparing the application in preventing/treating pulmonary hypertension drug 上海颢峰医药科技有限公司 2018-12-04 — — CN claimed
CN-101721379-B Cefuroxime sodium suspension powder injection HAINAN MEILANSHIKE PHARMA CO 2011-02-02 — — CN claimed
CN-101721379-A cefuroxime sodium suspension powder injection HAINAN MEILANSHIKE PHARMACEUTI 2010-06-09 — — CN claimed
US-4775750-A Process for preparing sodium cefuroxime GLAXO GROUP LIMITED (GB) 1988-10-04 — — US claimed
US-4298732-A Crystallization process GLAXO GROUP LIMITED (GB) 1981-11-03 — — US claimed
US-4277601-A Preparation of sodium cefuroxime GLAXO GROUP LIMITED (GB) 1981-07-07 — — US claimed
JP-55111490-A — — None — — JP disclosed
JP-60075485-A — — None — — JP disclosed
US-20250197401-A1 PURINONE DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2025-06-19 — — US disclosed
CN-120037191-A Freeze-drying process preparation method of sodium cefuroxime axetil powder injection for injection 浙江惠迪森药业有限公司 2025-05-27 — — CN disclosed
US-4277601-A Preparation of sodium cefuroxime GLAXO GROUP LIMITED (GB) 1981-07-07 — — US disclosed
US-4277601-A Preparation of sodium cefuroxime GLAXO GROUP LIMITED (GB) 1981-07-07 — — US disclosed
US-4277601-A Preparation of sodium cefuroxime GLAXO GROUP LIMITED (GB) 1981-07-07 — — US disclosed
JP-S55111490-A IMPROVEMENT ON MANUFACTURE OF SODIUM CEFUROXIME GLAXO GROUP LTD 1980-08-28 — — JP disclosed
US-4128715-A LYSINE SALT OF CERFUROXIME GLAXO LABORATORIES LIMITED (GB) 1978-12-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250197401-A1 PURINONE DERIVATIVE BTK, KIT, SYK TDP1 1653/4885HSD17B10 3011/4885NR1I2 431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback